PREZISTA (darunavir) Janssen prods Patent: 8,518,987 Expiration: Aug 16, 2024 See More … For more information on how DrugPatentWatch can […]
Drug Patent Expirations for the Week of August 11, 2024 Read Post »
Annual Drug Patent Expirations for NINLARO Ninlaro is a drug marketed by Takeda Pharms Usa and is included in one
New patent expiration for Takeda Pharms drug NINLARO Read Post »
Annual Drug Patent Expirations for OPANA+ER Opana Er is a drug marketed by Endo Pharms and is included in two
New patent expiration for Endo Pharms drug OPANA ER Read Post »
OPANA ER (oxymorphone hydrochloride) Endo pharms Patent: 8,114,383 Expiration: Aug 8, 2024 See More … For more information on how
Drug Patent Expirations for the Week of August 4, 2024 Read Post »
Annual Drug Patent Expirations for ACUVAIL Acuvail is a drug marketed by Abbvie and is included in one NDA. It
Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Mayne Pharma and is included in one NDA.
New patent expiration for Mayne Pharma drug RHOFADE Read Post »
Annual Drug Patent Expirations for LIVALO Livalo is a drug marketed by Kowa Co and is included in one NDA.
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Annual Drug Patent Expirations for INVOKAMET Invokamet is a drug marketed by Janssen Pharms and is included in two NDAs.
New patent expiration for Janssen Pharms drug INVOKAMET Read Post »
Get fresh news and insights, drug patent expirations & more…
